FGF2 and breast cancer: Similarly to its role in HSCs, FGF-2 also supports the dormancy of hormone receptor-positive BC cells through dual signaling by FGF-2-induced re-expression of integrin α5β1, which binds to microenvironmental fibronectin [98,119,120,121].